Dressings and topical agents for arterial leg ulcers

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 6, 2015, Pages

  Forster, Rachel ^a   Pagnamenta, Fania ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KETANSERIN; MACROGOL; PLACEBO; ANTITHROMBOCYTIC AGENT; MACROGOL DERIVATIVE; OINTMENT;

ARTERY DISEASE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG FORMULATION; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE COST; HUMAN; LEG ULCER; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; ULCER HEALING; ARTERY; OCCLUSIVE DRESSING; OINTMENT; THERAPEUTIC USE; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, TOPICAL; ARTERIES; HUMANS; KETANSERIN; LEG ULCER; OCCLUSIVE DRESSINGS; OINTMENTS; PLATELET AGGREGATION INHIBITORS; POLYETHYLENE GLYCOLS; WOUND HEALING;

EID: 84957789813     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001836.pub3     Document Type: Review

References (90)

1. Rooman RP, Janssen H. Ketanserin promotes wound healing: clinical and preclinical results. Progress in Clinical and Biological Research 1991;365:115-28.
2. Altman MA, Richter IH, Kaplan LH. Use of an aqueous triple iodine solution in the treatment of chronic leg ulcers and gangrene. Angiology 1976;27(3):181-7.
3. Armstrong SH, Brown DA, Hill E, Ruckley CV, Pucheault M, Hofman DA. A randomized comparative clinical trial of a new hydrofibre dressing versus an alginate dressing in the treatment of exuding leg ulcer. Proceedings of the 5th European Conference on Advances in Wound Management; 1995, 21-24 November. Harrogate, UK, 1996:197-8.
4. Armstrong SH, Ruckley CV. Use of a fibrous dressing in exuding leg ulcers. Journal of Wound Care 1997;6(7):322-4.
5. Bale S, Hagelstein S, Banks V, Harding KG. Costs of dressings in the community. Journal of Wound Care 1998;7(7):327-30.
6. Banks V, Bale S, Harding K, Harding EF. Evaluation of a new polyurethane foam dressing. Journal of Wound Care 1997;6(6):266-9.
7. Bassetti F, Damiani S, De GM, Peruzy AD. Controlled clinical trial of a drug in the treatment of leg ulcer [Sperimentazione clinica controllata di un farmaco nel trattamento dell'ulcera della gamba]. Giornale Italiano Di Dermatological - Minerva Dermatologica 1970;45(3):133-4.
8. Boxer AM, Gottesman N, Bernstein H, Mandl I. Debridement of dermal ulcers and decubiti with collagenase. Geriatrics 1969;24(7):75-86.
9. Casoni P. Randomized trial of a new dressing in the treatment of chronic non-healing ulcers. 15th Annual Congress of the American College of Phlebology, La Quinta, California. 2001.
10. Chaloner DM, Milward PA, Skitt PJ. A community-based clinical trial of three dressings in the treatment of leg ulceration. 1st European Conference on Advances in Wound Management, 1991, 4-6 September, Cardiff UK. 1991:148-9.
11. Marques da Costa R, Jesus FM, Aniceto C, Mendes M. Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers. American Journal of Surgery 1997;173(3):165-8.
12. Daltrey DC, Cunliffe WJ. A double-blind study of the effects of benzoyl peroxide 20% and eusol and liquid paraffin on the microbial flora of leg ulcers. Acta Dermato-Venereologica 1981;61(6):575-7.
13. Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. Journal of the American Academy of Dermatology 1998;39(5 Pt 1):737-40.
14. Fumal I, Braham C, Paquet P, Pierard-Franchimont C, Pierard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof of concept study. Dermatology 2002;204 (Suppl 1):70-4.
15. Gago Fornells M, Verdu Soriano J, Garcia Conzalez RF, Guerrero JJ, Rueda Lopez J, Gaztelu Valdes V. Maceration of the skin surrounding the lesions in leg ulcers. Comparison of seven groups of dressings for moist dressing. Proceedings of the 12th Conference of the European Wound Management Association. GNEAUPP - EWMA, 2002:132.
16. Gamborg Nielsen P, Munk Madsen S, Stromberg L. Treatment of chronic leg ulcers with a hydrocolloid dressing. Acta Dermato-Venereologica Supplementum (Stockholm) 1989;152:1-12.
17. Gibson B, Harper DR, Nelson EA, Prescott RJ, Ruckley CV. Comparison of a knitted viscose dressing and a hydrocolloid dressing in the treatment of arterial and diabetic leg ulcers. Phlebology '95: Proceedings of the XII Congress Union Internationale De Phlebologie. John Libbey Co. Ltd, 1986:159-60.
18. Harding KG, Price P, Robinson B, Thomas S, Hofman D. Cost and dressing evaluation of hydrofiber and alginate dressings in the management of community-based patients with chronic leg ulceration. Wounds: A Compendium of Clinical Research and Practice 2001;13:229-36.
19. Harding KG, Price P, Robinson B, Thomas S, Holman D. Cost and dressing evaluation of a hydrofiber and alginate dressing in the management of community-based patients with chronic leg ulceration. Ostomy/wound management 2001;47:52.
20. Robinson B, Harding K, Thomas S, Cherry G. Does the dressing make a difference? A comparative cost-effectiveness clinical trial of two modern primary dressings on leg ulcers. European Wound Management Association Conference; 1997, 27-29 April; Milan, Italy. 1997:63-4.
21. Robinson BJ. An open, prospective, randomized multi-centre study of a new hydrofibre dressing, Aquacel, in comparison with an alginate in the management of leg ulcers in the UK community. Proceedings of the 6th European conference on advances in wound management; 1-4 October, 1996; Amsterdam. 1997:155.
22. Hartman D, Coetzee JC. Two US practitioners' experience of using essential oils for wound care. Journal of Wound Care 2002;11(8):317-20.
23. Holm J, Andren B, Grafford K. Pain control in the surgical debridement of leg ulcers by the use of a topical lidocaine--prilocaine cream, EMLA. Acta Dermato-Venereologica 1990;70(2):132-46.
24. Holst RG, Kristofferson A. Lidocaine-prilocaine cream (EMLA Cream) as a topical anaesthetic for the cleansing of leg ulcers. The effect of length of application time. European Journal of Dermatology 1998;8(4):245-7.
25. Huber L. Role of Klion ointment in the treatment of crural ulcer. Therapia Hungarica 1991;39(3):148-50.
26. Ishibashi Y, Eto T, Anzai T, Jitsukawa K, Harada S, Nakanishi H, et al. Clinical study of a new hydrocolloid dressing, Comfeel Ulcus, in dermal ulcers: well-controlled comparative study with Duo Active [Atarashii Sosho Hifukuzai Comfeel Ulcus no Hifu Kaiyo ni Taisuru Rinsho Shiken Seiseki: Futoho ni Yoru Duo Active to no Hikaku]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1990;6(6):1227-40.
27. Jansen M, Horst JVD, Valk PVD, Kuks P, Zylicz Z, Sorge AV. Pain-relieving properties of topically applied morphine on arterial leg ulcers: a pilot study. Journal of Wound Care 2009;18(7):306-11.
28. Janssen PA, Janssen H, Cauwenbergh G, De Doncker P, De Beule K, Lewi P, et al. Use of topical ketanserin in the treatment of skin ulcers: a double-blind study. Journal of the American Academy of Dermatology 1989;21(1):85-90.
29. Johnson CR, Repper J. A double-blind, placebo controlled study of lidocaine/prilocaine cream (EMLA (R) 5%) used as topical analgesic for cleansing and re-dressing of leg ulcers. Astra Zeneca 1992.
30. Jorgensen B, Thomsen JK. Safety and efficacy of a new hydrocapillary dressing in the treatment of leg ulcers. 13th Conference of the European Wound Management Association; 2003, 22-24 May; Pisa, Italy. 2003:221.
31. Jørgensen B, Polignano R, Mantovani M, Orsted H. Effects of a foam dressing with ibuprofen on wound pain from arterial leg ulcers and vasculitic ulcers. EWMA Journal 2009;9:193.
32. Kalis B. Clinical evaluation of Granuflex and dextranomer dressing in leg ulcers. 2nd European Conference on Advances in Wound Management; 1992, 20-23 October; Harrogate, UK. 1993:212.
33. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Progress in Clinical and Biological Research 1988;266:319-29.
34. Knighton DR, Loss L. Design and implementation of clinical studies in chronic nonhealing wounds. Progress in Clinical and Biological Research 1991;365:67-76.
35. Kordestani S, Shahrezaee M, Tahmasebi MN, Hajimahmodi H, Haji Ghasemali D, Abyaneh MS. A randomised controlled trial on the effectiveness of an advanced wound dressing used in Iran. Journal of Wound Care 2008;17(7):323-7.
36. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. Journal of Vascular Surgery 1991;14(4):526-32.
37. Larsen AM, Andersen KE, Berg BK. A comparative study on the effect and function of Comfeel Purilon versus IntraSite gel on leg ulcers. European Wound Management Association Conference; 1997, 27-29 April; Milan, Italy. 1997:44-6.
38. Leaper DJ, Stewart AJ. A comparative trial of Sherisorb gel and cadexomer iodine: problems of community-based trials involving chronic leg ulcers. In: Turner TD, Schmidt RJ, Harding KG editor(s). Advances in Wound Management. Chicester: Wiley, 1986:121-6.
39. Leaper DJ, Cameron S, Hewitt H, Winter A, Lucarotti ME. A community- and hospital-based comparative evaluation of Comfeel ulcer dressing for chronic leg ulcers. Journal of Dermatological Treatment 1991;2(3):103-6.
40. Luongo C, Sammartino A, Mascolo L, Campitiello F, Golino M, Luongo M. Advanced dressings and oxigen-ozone therapy to treat ulcer's in chronic obliterant peripheral artheriopaties (AOCP). Proceedings of the 13th Conference of the European Wound Management Association. Pisa: EWMA, 2003:232.
41. Mian E, Mian M, Beghe F. Lyophilized type-I collagen and chronic leg ulcers. International Journal of Tissue Reactions 1991;13(5):257-69.
42. Milward P. Examining hydrocolloids. Nursing Times 1991;87(36):70, 72-4.
43. Moss C, Taylow A, Shuster S. Comparative study of cadexomer iodine and dextranomer in chronic leg ulcers. Scottish Medical Journal 1984;25:54.
44. Motta GJ, Milne CT, Corbett LQ. Impact of antimicrobial gauze on bacterial colonies in wounds that require packing. Ostomy Wound Management 2004;50:48-62.
45. Munter KC, Beele H, Russell L, Crespi A, Grochenig E, Basse P, et al. Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. Journal of Wound Care 2006;15(5):199-206.
46. Neander KD, Hesse F. The protective effects on wound edges of a new preparation. Nursing Times 2004;100(4):61-3.
47. Nyfors A, Helland S, Solberg V. Synthaderm in the treatment of leg ulcers. A prospective controlled study. Tidsskrift for den Norske Laegeforening 1982;102:424-5.
48. Pendse AK, Sharma A, Sodani A, Hada S. Topical phenytoin in wound healing. International Journal of Dermatology 1993;32(3):214-7.
49. Polignano R, Abel M, Andriessen A. 2004. The effect of moist wound healing dressing on microcirculation in leg ulcers. A pilot study. 2nd World Union of Wound Healing Societies Meeting; 2004, 8-13 July; Paris. 2004.
50. Polignano R, Turrini P, Andreissen A. The effect of microcirculation in leg ulcers comparing traditional vs MWH dressings - a pilot study. 11th European Tissue Repair Society Annual Conference; 2001 5-8 September; Cardiff, Wales. 2001:44.
51. Quatresooz P, Kharfi M, Paquet P, Vroome V, Cauwenbergh G, Pierard GE. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. Journal of the European Academy of Dermatology and Venereology 2006;20(3):277-81.
52. Schmutz JL. Comparison of the new hydrofibre dressing Aquacel and a conventional dressing for the treatment of leg ulcers. Proceedings of the 6th European Conference on Advances in Wound Management; 1-4 October, 1996; Amsterdam. 1997:88.
53. Senet P, Vicaut E, Beneton N, Debure C, Lok C, Chosidow O. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Archives of Dermatology 2011;147(8):926-30.
54. Serra N, Torres OG, Romo MI, Llovera JM, Vigil Escalera LJ, Soto MA, et al. [Hydro-colloidal dressings which release hydro-active silver]. Revista de Enfermeria 2005;28(2):13-8.
55. Sibbald RG, Coutts P, Woo KY. Reduction of bacterial burden and pain in chronic wounds using a new polyhexamethylene biguanide antimicrobial foam dressing-clinical trial results. Advances in Skin & Wound Care 2011;24(2):78-84.
56. Steed D, Goslen JB, Hambley R, Abell E, Hebda P, Webster M. Clinical trials with purified platelet releasate. Progress in Clinical and Biological Research 1991;365:103-13.
57. Stromberg HE, Agren MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. British Journal of Dermatology 1984;111(4):461-8.
58. Svedman P. Irrigation treatment of leg ulcers. Lancet 1983;2(8349):532-4.
59. Tarvainen K. Cadexomer iodine (Iodosorb) compared with dextranomer (Debrisan) in the treatment of chronic leg ulcers. Acta chirurgica Scandinavica Supplementum 1988;544:57-9.
60. Thomas S. Sorbsan in the management of leg ulcers. Pharmaceutical Journal 1989;243:706-9.
61. Varelias A, Cowin AJ, Adams D, Harries RH, Cooter RD, Belford DA, et al. Mitogenic bovine whey extract modulates matrix metalloproteinase-2, -9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers. Wound Repair and Regeneration 2006;14(1):28-37.
62. Vin F, Dubertret L, Beylot C. The cost-effectiveness of a hydrocolloid hydrogel dressing in the management of necrotic and sloughy leg ulcers, in comparison with a polysaccharide paste. European Wound Management Association Conference 1997, 27-29 April; Milan, Italy. 1997.
63. Vuerstaek JDD, Vainas T, Wuite J, Nelemans P, Neumann MHA, Veraart, et al. State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. Journal of Vascular Surgery 2006;44(5):1029-37.
64. Wanger L, Eriksson G, Karlsson A. Analgesic effect and local reactions of repeated application of EMLA(R) (Lidocaine/Prilocaine) cream for the cleansing of leg ulcers. Clinical Dermatology in the year 2000 London 22-25 May 1990. 1990:164.
65. Weed B, Davis MDP, Felty CL, Liedl DA, Pineda AA, Moore SB, et al. Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: a pilot study using a randomized, double-blind, placebo-controlled trial. Wounds: A Compendium of Clinical Research and Practice 2004;16:273-82.
66. Wollina U. Topical therapy of chronic wounds with a new hydropolymer dressing - Clinical experience in 478 patients. Zeitschrift fur Hautkrankheiten 1997;72(7):500-6.
67. Wu P, Nelson EA, Reid WH, Ruckley CV, Gaylor JD. Water vapour transmission rates in burns and chronic leg ulcers: influence of wound dressings and comparison with in vitro evaluation. Biomaterials 1996;17(14):1373-7.
68. Zykova SN, Balandina KA, Vorokhobina NV, Kuznetsova AV, Engstad R, Zykova TA. Macrophage stimulating agent soluble yeast beta-1, 3/1, 6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study. Journal of Diabetes Investigation. Blackwell Publishing, 2014; Vol. 5, issue 4:392-9.
69. Gibson B. A cost effectiveness comparison of two gels in the treatment of sloughy leg ulcers. Symposium on Advanced Wound Care and Medical Research Forum on Wound Repair; 1995, April; San Diego, CA. 1995.
70. Morely de BS, Cirelli N, Halmai O, Sanjuan E, Piquero MJ, Arbona Jea. Argentic sulfadiazine in lower limbs ulcers: double-blinded study. Archivos Venezolanos de Farmacologia Y Terapeutica 1990;9:116-9.
71. British National Formulary, British Medical Association, British Royal Pharmaceutical Society of Great Britain. A5 Wound management products and elasticated garments. British National Formulary 65. London: British Medical Association, 2013:1009.
72. Callam MJ, Ruckley CV, Dale JJ, Harper DR. Hazards of compression treatment of the leg: an estimate from Scottish surgeons. British Medical Journal 1987;295(6610):1382.
73. Graham ID, Harrison MB, Nelson EA, Lorimer K, Fisher F. Prevalence of Lower-Limb Ulceration: A Systematic Review of Prevalence Studies. Advances in Skin & Wound Care 2003;16(6):305-16.
74. Grey JE, Enoch S, Harding KG. Venous and arterial ulcers. BMJ 2006;332:347-50.
75. Higgins JP, Thompson SG, Deeks JT, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
76. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org.
77. Madden M. Alienating evidence based medicine vs. Innovative medical device marketing: a report on the evidence debate at a Wounds conference. Social Science & Medicine 2012;74:2056-2.
78. O'Meara S, Cullum N, Nelson EA, Dumville JC. Compression for venous leg ulcers. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000265.pub3]
79. O'Meara S, Martyn-St James M. Alginate dressings for venous leg ulcers. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD010182.pub2]
80. O'Meara S, Martyn-St James M. Foam dressings for venous leg ulcers. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD009907.pub2]
81. Palfreyman SSJ, Nelson EA, Lochiel R, Michaels JA. Dressings for healing venous leg ulcers. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001103.pub2]
82. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
83. Ribeiro CTD, Dias FAL, Fregonezi GAF. Hydrogel dressings for venous leg ulcers. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD010738]
84. Ribeiro CTD, Fregonezi GAF, Resqueti VR, Dornelas de Andrade A, Dias FAL. Hydrocolloid dressings for healing venous leg ulcers. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD010918]
85. 120 Management of chronic venous leg ulcers, A national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN) August 2010:http://sign.ac.uk/pdf/sign120.pdf (accessed March 2015).
86. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
87. Vanhoutte P, Amery S, Birkenhager W, Breckenridge A, Buhler F, Distler A. Serotenergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension 1988;11(2):111-33.
88. Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-4.
89. Nelson EA, Bradley MD. Dressings and topical agents for arterial leg ulcers. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD001836]
90. Nelson EA, Bradley MD. Dressings and topical agents for arterial leg ulcers. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD001836.pub2]